The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The tumor necrosis factor (TNF)-family cytokine TL1A (TNFSF15) costimulates T cells and promotes diverse T cell-dependent models of autoimmune disease through its receptor DR3. TL1A polymorphisms also confer susceptibility to inflammatory bowel disease. Here, we find that allergic pathology driven by constitutive TL1A expression depends on interleukin-13 (IL-13), but not on T, NKT, mast cells, or commensal intestinal flora. Group 2 innate lymphoid cells (ILC2) express surface DR3 and produce IL-13 and other type 2 cytokines in response to TL1A. DR3 is required for ILC2 expansion and function in the setting of T cell-dependent and -independent models of allergic disease. By contrast, DR3-deficient ILC2 can still differentiate, expand, and produce IL-13 when stimulated by IL-25 or IL-33, and mediate expulsion of intestinal helminths. These data identify costimulation of ILC2 as a novel function of TL1A important for allergic lung disease, and suggest that TL1A may be a therapeutic target in these settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Reciprocal interactions of the intestinal microbiota and immune system
Maynard, C. L., Elson, C. O., Hatton, R. D., & Weaver, C. T. (2012) · Nature · doi:10.1038/nature11551 · Cited by 1,598 · cited 1×
“immune cells in the gut.(28) We previously found that restricting the T-cell repertoire with the OT-II TCR transgene did not reduce the intestinal hyperplasia in TL1A transgenic mice,(16) suggesting that T-cell antigens derived from intestinal microbiota were not required.”
BackgroundInnate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus
Monticelli (2011) · PubMed · doi:10.1031/ni.2131 · Cited by 1,286
Mjösberg, J. M., Trifari, S., Crellin, N. K., Peters, C. P., van Drunen, C. M., Piet, B., Fokkens, W. J., Cupedo, T., & Spits, H. (2011) · Nature Immunology · doi:10.1038/ni.2104 · Cited by 1,166 · cited 1×
“Human counterparts of ILC2 have been found in the nasal passages of patients with allergic rhinitis (45) and in the lung (44).”
BackgroundChiaramonte, M. G., Donaldson, D. D., Cheever, A. W., & Wynn, T. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7325 · Cited by 603 · cited 1×
“During schistosomal infection, host IL-13 drives the granulomatous response that contains parasite eggs in the liver, but also promotes hepatic fibrosis.(36,37) In response to S.”
BackgroundSelf-citation
Cited by
The biology of innate lymphoid cells
Artis, D., & Spits, H. (2015) · Nature · doi:10.1038/nature14189 · Cited by 1,634
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis
Klose, C. S. N., & Artis, D. (2016) · Nature Immunology · doi:10.1038/ni.3489 · Cited by 951
Barrier Epithelial Cells and the Control of Type 2 Immunity
Hammad, H., & Lambrecht, B. N. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.007 · Cited by 847
The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory Responses
Ward-Kavanagh, L. K., Lin, W. W., Šedý, J. R., & Ware, C. F. (2016) · Immunity · doi:10.1016/j.immuni.2016.04.019 · Cited by 463
CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22
Longman, R. S., Diehl, G. E., Victorio, D. A., Huh, J. R., Galan, C., Miraldi, E. R., Swaminath, A., Bonneau, R., Scherl, E. J., & Littman, D. R. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20140678 · Cited by 383
Innate Lymphoid Cells in Inflammation and Immunity
McKenzie, A. N. J., Spits, H., & Eberl, G. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.006 · Cited by 368
Self-citationDevelopmental Acquisition of Regulomes Underlies Innate Lymphoid Cell Functionality
Shih, H.-Y., Sciumè, G., Mikami, Y., Guo, L., Sun, H.-W., Brooks, S. R., Urban, J. F., Davis, F. P., Kanno, Y., & O’Shea, J. J. (2016) · Cell · doi:10.1016/j.cell.2016.04.029 · Cited by 334
“5 mg/ml Liberase TL (Roche) for 1 hr followed by purification with 40% Percoll (GE Healthcare) (Meylan et al., 2014).”
Self-citationType 2 immunity: Expanding our view
Lloyd, C. M., & Snelgrove, R. J. (2018) · Science Immunology · doi:10.1126/sciimmunol.aat1604 · Cited by 334
The group 2 innate lymphoid cell ( ILC 2) regulatory network and its underlying mechanisms
Kabata, H., Moro, K., & Koyasu, S. (2018) · Immunological Reviews · doi:10.1111/imr.12706 · Cited by 293
Lessons learned — resolving the enigma of genetic factors in IBS
Gazouli, M., Wouters, M. M., Kapur-Pojskić, L., Bengtson, M.-B., Friedman, E., Nikčević, G., Demetriou, C. A., Mulak, A., Santos, J., & Niesler, B. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.206 · Cited by 86
Insights into Group 2 Innate Lymphoid Cells in Human Airway Disease
Karta, M. R., Broide, D. H., & Doherty, T. A. (2016) · Current Allergy and Asthma Reports · doi:10.1007/s11882-015-0581-6 · Cited by 77
Metadata
- Authors
- Meylan, F., Hawley, E. T., Barron, L., Barlow, J. L., Penumetcha, P., Pelletier, M., Sciumè, G., Richard, A. C., Hayes, E. T., Gomez-Rodriguez, J., Chen, X., Paul, W. E., Wynn, T. A., McKenzie, A. N. J., & Siegel, R. M.
- Venue
- Mucosal Immunology
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 7
- Issue
- 4
- Pages
- 958-968
- ISSN
- 1933-0219 (ISSN-L)
- OpenAlex
- W2070151667
- Cited by
- 149
- References
- 5
- FWCI
- 6.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.